Abeona Therapeutics Inc vs AES Corp — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while AES Corp trades at $14.7 (market cap $10.49B). The key difference: AES Corp is far larger — about 24.9× Abeona Therapeutics Inc's market cap, and AES Corp pays a 4.79% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | AES | |
|---|---|---|
Market Cap | $421.19M | $10.49B |
Sector | Health | Utilities |
52-Week High | $7.45 | $17.28 |
52-Week Low | $4.17 | $12.51 |
Enterprise Value | $276.10M | $40.75B |
Dividend Yield | — | 4.79% |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →AES is a global power company operating across 14 countries and 4 continents. Its current generation portfolio as of year-end 2021 consists of over 31 gigawatts of generation, with the generation mix composed of renewables (43%), gas (32%), coal (23%), and oil (2%). The company has 3.5 gigawatts of generation under construction. AES has majority ownership and operates six electric utilities distributing power to 2.6 million customers.
Read more on AES →